Pricing Log in Create free account

Immuneering Corporation (IMRX) vs Q32 Bio Inc. (QTTB)

Immuneering Corporation and Q32 Bio Inc. are both Biotechnology companies. Immuneering Corporation and Q32 Bio Inc. are of similar size ($235.5M and $231.3M). Immuneering Corporation has negative trailing earnings, so its P/E is not meaningful; Q32 Bio Inc. trades at 2.5×. Immuneering Corporation grew revenue faster over the last twelve months: −84.8% against −307.3%. Across the 12 metrics below, Q32 Bio Inc. leads on 10 and Immuneering Corporation on 2.

Valuation

Metric IMRX QTTB Biotechnology median
P/E n/m 2.49 8.50
P/S 732.69 n/m 9.71
P/B 1.22 1.44 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 259.82 (8.25) 9.21
Earnings yield (28.97%) 40.16% (33.15%)
Free cash flow yield (24.54%) (8.43%) (25.50%)

Profitability

Metric IMRX QTTB Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (52.15%) 72.14% (56.36%)
Return on assets (47.31%) 37.13% (48.04%)
Return on invested capital (97.14%) 0.00% 0.00%

Growth

Metric IMRX QTTB Biotechnology median
Revenue growth (TTM) (84.76%) (307.33%) 6.02%
EPS growth (last fiscal year) 37.75% 148.96% 30.26%
Revenue growth, 5-year CAGR — 100.32% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMRX QTTB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 19.47 20.30 4.72
Net debt to EBITDA 2.94 (2.21) 0.96

Dividend

Metric IMRX QTTB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMRX QTTB Biotechnology median
Market cap 235.50m 231.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack